Add to my selection

SPRAVATO

Medicine - Posted on Sep 05 2024

Active substance (DCI)

eskétamine

history (4)

7/17/24

SPRAVATO (esketamine) - Depressive

Summary of opinion Favourable opinion for maintenance of reimbursement in combination with a SSRI or SNRI only for the treat...

CAV :
54321

icône flèche
9/22/21

SPRAVATO 28 mg (esketamine)

Key points Unfavourable opinion for reimbursementco-administered with an oral antidepressant therapy, in adults with a moder...

icône flèche
6/24/20

SPRAVATO

Key points Favourable opinion for reimbursement in combination with a SSRI or SNRI for the treatment of treatment-resistant ...

CAV :
54321

icône flèche

Technical information

ATC code

N06AX27

Manufacturer

JANSSEN-CILAG

Presentation

SPRAVATO 28 mg, solution pour pulvérisation nasale
1 flacon en verre de 0,2 mL contenant 1 dispositif pour pulvérisation nasale (Code CIP : 34009 550 698 4 3)

All our publications

Depression and mood disorders

Drug therapy

My account

You do not have a saved search

SPRAVATO

SPRAVATO (esketamine) - Depressive

SPRAVATO 28 mg (esketamine)

SPRAVATO

Follow us :